interesting article from us cancer site, page-5

i think it might be worthwhile doing some research into the current market leader in the field and comparing their test to HTX's. With their success rate being that high (97%) and poised to increase after the upcoming clinical trials, it would be very hard for another bio to top them in terms of results...thus the only competition they could face would be based on price of the tests, which if i was going to be tested i woiuld certainly go for the best test available. Early days yet but we may see a monopoly market for HTX in the future!!

Gl to holders

Cheers!